79 related articles for article (PubMed ID: 23092578)
21. Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.
Vaghefi H; Neet KE
Oncogene; 2004 Oct; 23(49):8078-87. PubMed ID: 15361854
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.
Kobayashi S; Lackey T; Huang Y; Bisping E; Pu WT; Boxer LM; Liang Q
FASEB J; 2006 Apr; 20(6):800-2. PubMed ID: 16469847
[TBL] [Abstract][Full Text] [Related]
23. [Multiple post-translational modifications implied in the gene expression regulation: example of the sumoylation of Ets factors].
de Launoit Y; Degerny C; Wohlkonig A; Baert JL
Bull Mem Acad R Med Belg; 2007; 162(5-6):299-305; discussion 306. PubMed ID: 18404999
[TBL] [Abstract][Full Text] [Related]
24. Simple histone acetylation plays a complex role in the regulation of gene expression.
Fukuda H; Sano N; Muto S; Horikoshi M
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):190-208. PubMed ID: 16980317
[TBL] [Abstract][Full Text] [Related]
25. Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy.
Bian J; Popovic ZB; Benejam C; Kiedrowski M; Rodriguez LL; Penn MS
Circ Res; 2007 Jun; 100(11):1626-33. PubMed ID: 17495229
[TBL] [Abstract][Full Text] [Related]
26. Combined haploinsufficiency of SF-1 and GATA4 does not reveal a genetic interaction in mouse gonadal development.
Pelusi C; Zhao L; Stallings NR; Parker KL
Sex Dev; 2007; 1(3):152-60. PubMed ID: 18391526
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.
Wu G; Shan J; Pang S; Wei X; Zhang H; Yan B
Transl Res; 2012 May; 159(5):376-82. PubMed ID: 22500510
[TBL] [Abstract][Full Text] [Related]
28. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
29. Transcription factors Csx/Nkx2.5 and GATA4 distinctly regulate expression of Ca2+ channels in neonatal rat heart.
Wang Y; Morishima M; Zheng M; Uchino T; Mannen K; Takahashi A; Nakaya Y; Komuro I; Ono K
J Mol Cell Cardiol; 2007 Jun; 42(6):1045-53. PubMed ID: 17498735
[TBL] [Abstract][Full Text] [Related]
30. Regulation of transcription factor activity by SUMO modification.
Ouyang J; Valin A; Gill G
Methods Mol Biol; 2009; 497():141-52. PubMed ID: 19107415
[TBL] [Abstract][Full Text] [Related]
31. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.
Usui T; Preiss JC; Kanno Y; Yao ZJ; Bream JH; O'Shea JJ; Strober W
J Exp Med; 2006 Mar; 203(3):755-66. PubMed ID: 16520391
[TBL] [Abstract][Full Text] [Related]
32. Post-translational modulation of pluripotency.
Cai N; Li M; Qu J; Liu GH; Izpisua Belmonte JC
J Mol Cell Biol; 2012 Aug; 4(4):262-5. PubMed ID: 22679102
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot.
Nemer G; Fadlalah F; Usta J; Nemer M; Dbaibo G; Obeid M; Bitar F
Hum Mutat; 2006 Mar; 27(3):293-4. PubMed ID: 16470721
[TBL] [Abstract][Full Text] [Related]
34. Role of transcription factor acetylation in the regulation of metabolic homeostasis.
Park JM; Jo SH; Kim MY; Kim TH; Ahn YH
Protein Cell; 2015 Nov; 6(11):804-13. PubMed ID: 26334401
[TBL] [Abstract][Full Text] [Related]
35. GATA4 transgenic mice as an in vivo model of congenital heart disease.
Han H; Chen Y; Liu G; Han Z; Zhao Z; Tang Y
Int J Mol Med; 2015 Jun; 35(6):1545-53. PubMed ID: 25873328
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators.
Jumppanen M; Kinnunen SM; Välimäki MJ; Talman V; Auno S; Bruun T; Boije Af Gennäs G; Xhaard H; Aumüller IB; Ruskoaho H; Yli-Kauhaluoma J
J Med Chem; 2019 Sep; 62(17):8284-8310. PubMed ID: 31431011
[TBL] [Abstract][Full Text] [Related]
37. Regulation of GATA4 transcriptional activity in cardiovascular development and disease.
Zhou P; He A; Pu WT
Curr Top Dev Biol; 2012; 100():143-69. PubMed ID: 22449843
[TBL] [Abstract][Full Text] [Related]
38. Functional mutant GATA4 identification and potential application in preimplantation diagnosis of congenital heart diseases.
Yu Y; Lei W; Yang J; Wei YC; Zhao ZL; Zhao ZA; Hu S
Gene; 2018 Jan; 641():349-354. PubMed ID: 29111206
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of a human embryonic stem cell line carrying a heterozygous GATA4
Ye L; Yu Y; Wang Y; Huang Y; Yu M; Lei W; Tang JM; Hu S
Stem Cell Res; 2021 May; 53():102393. PubMed ID: 34088018
[TBL] [Abstract][Full Text] [Related]
40. The Epigenetic Regulation of GATA4-Dependent Brain Natriuretic Peptide Expression during Alcohol Withdrawal.
Glahn A; Rhein M; Heberlein A; Muschler M; Kornhuber J; Frieling H; Bleich S; Hillemacher T
Neuropsychobiology; 2016; 74(3):131-138. PubMed ID: 28441648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
